Perioperative Management of Oral Glucose-lowering Drugs in the Patient with Type 2 Diabetes

被引：35
|
作者：
Preiser, Jean-Charles [1 ]
Provenzano, Bruna [1 ]
Mongkolpun, Wasineeart [1 ]
Halenarova, Katarina [1 ]
Cnop, Miriam [2 ,3 ]
机构：
[1] Free Univ Brussels, Dept Intens Care, Brussels, Belgium
[2] Free Univ Brussels, Erasmus Hosp, Div Endocrinol, Brussels, Belgium
[3] Free Univ Brussels, Ctr Diabet Res, Brussels, Belgium
来源：
ANESTHESIOLOGY | 2020年 / 133卷 / 02期
关键词：
COTRANSPORTER-2; INHIBITORS; CARDIOVASCULAR EVENTS; LACTIC-ACIDOSIS; BLOOD-GLUCOSE; METFORMIN; HYPERGLYCEMIA; DEATH; RISK; MORTALITY; SURGERY;
D O I：
10.1097/ALN.0000000000003237
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
[No abstract available]
引用
收藏
页码：430 / 438
页数：9
相关论文
共 50 条
  • [31] Management of Glucose-Lowering Therapy in Older Adults with Type 2 Diabetes: Challenges and Opportunities
    Doucet, Jean
    Gourdy, Pierre
    Meyer, Laurent
    Benabdelmoumene, Nabil
    Bourdel-Marchasson, Isabelle
    CLINICAL INTERVENTIONS IN AGING, 2023, 18 : 1687 - 1703
  • [32] UTILIZATION TRENDS OF GLUCOSE-LOWERING DRUGS FOR TYPE 2 DIABETES IN OLDER ADULTS WITH AND WITHOUT DEMENTIA
    Gopalakrishnan, Chandrasekar
    Kim, Dae
    Patorno, Elisabetta
    INNOVATION IN AGING, 2022, 6 : 468 - 469
  • [33] New glucose-lowering drugs for reducing cardiovascular risk in patients with type 2 diabetes mellitus
    Gorgojo-Martinez, J. J.
    HIPERTENSION Y RIESGO VASCULAR, 2019, 36 (03): : 145 - 161
  • [34] The Impact of Glucose-Lowering Drugs on Sarcopenia in Type 2 Diabetes: Current Evidence and Underlying Mechanisms
    Massimino, Elena
    Izzo, Anna
    Riccardi, Gabriele
    Della Pepa, Giuseppe
    CELLS, 2021, 10 (08)
  • [35] Association study of six type 2 diabetes genes and glucose-lowering effect of sulfonylurea drugs
    Schroner, Z.
    Javorsky, M.
    Klimcakova, L.
    Dobrikova, M.
    Habalova, V.
    Babjakova, E.
    Zidzik, J.
    Fabianova, M.
    Slaba, E.
    Kozarova, M.
    Tkacova, R.
    Salagovic, J.
    Tkac, I.
    DIABETOLOGIA, 2011, 54 : S123 - S123
  • [36] Hypertension in type 2 diabetes: impact of glucose-lowering medications
    Krentz, Andrew J.
    CARDIOVASCULAR ENDOCRINOLOGY, 2016, 5 (04): : 137 - 143
  • [37] Cardiovascular prevention in type 2 diabetes mellitus patients: the role of oral glucose-lowering agents
    Anselmino, Matteo
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2009, 23 (06) : 427 - 433
  • [38] Influence of Supervised Disease Understanding and Diabetes Self-Management on Adherence to Oral Glucose-Lowering Treatment in Patients with Type 2 Diabetes
    John Doupis
    Theodoros Alexandrides
    Moses Elisaf
    Andreas Melidonis
    Stavros Bousboulas
    Anastasia Thanopoulou
    Emmanouil M. Pagkalos
    Iakovos Avramidis
    Angelos Pappas
    Eleni Arvaniti
    Eugenia Karamousouli
    Bernd Voss
    Nikolaos Tentolouris
    Diabetes Therapy, 2019, 10 : 1407 - 1422
  • [39] Influence of Supervised Disease Understanding and Diabetes Self-Management on Adherence to Oral Glucose-Lowering Treatment in Patients with Type 2 Diabetes
    Doupis, John
    Alexandrides, Theodoros
    Elisaf, Moses
    Melidonis, Andreas
    Bousboulas, Stavros
    Thanopoulou, Anastasia
    Pagkalos, Emmanouil M.
    Avramidis, Iakovos
    Pappas, Angelos
    Arvaniti, Eleni
    Karamousouli, Eugenia
    Voss, Bernd
    Tentolouris, Nikolaos
    DIABETES THERAPY, 2019, 10 (04) : 1407 - 1422
  • [40] Sarcopenia with glucose-lowering drugs
    Reactions Weekly, 2021, 1875 (1) : 12 - 12
12345